[The following is a paid advertisement.]

Illinois hospitals and Federally Qualified Health Centers (FQHCs) are standing up for their patients and against the disinformation about 340B that Big Pharma is spreading. At a March 1 rally in Chicago for House Bill 2371 SA 2—the Patient Access to Pharmacy Protection Act—patients, physicians, and hospital and FQHC leaders shared the true impact of 340B.

“It’s about our patients,” Dr. Lisa Green, CEO and co-founder of Family Christian Health Center, said at the rally of about 500 people, noting the importance of a system of care, from primary care at FQHCs to specialty care at hospitals.

“UChicago Medicine is part of this broader ecosystem. We are here serving some of our most vulnerable communities in our city and across the state,” said Catina Latham, Senior Vice President for Community Health Transformation and Chief Equity Officer with UChicago Medicine.

The University of Chicago Medical Center is one of Illinois’ largest providers of Medicaid-insured care. 340B savings have funded initiatives there and at UChicago Medicine Ingalls Memorial Hospital, including expanded emergency and trauma services, and new clinic sites and community health workers.

“HB 2371 SA 2 does not expand 340B, it protects it,” Latham said. “We are committed to closing the health gaps on the South Side and in the Southland, but we cannot do it alone, and we cannot do it without 340B.”

Stand with patients, hospitals and FQHCs: Vote YES on HB 2371 SA 2! Learn more.